The Report Guru

According to the new market research report Breast Cancer Liquid Biopsy Market is expected to reach USD 411.1 million by 2022 from USD 145.4 million in 2017, at a CAGR of 23.1%. The key factors driving the growth of this market include increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D. By circulating biomarkers, cell-free DNA (cfDNA) is expected to account for the largest market share in 2017 Based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vehicles (EVs), and other circulating biomarkers. In 2017, the cfDNA segment is expected to account for the largest share of the breast cancer liquid biopsy market. The ability of cfDNA for easy and early as

According to research the research report  Ambulatory EHR Market   is expected to reach USD 5.20 billion by 2021 from USD 3.92 billion in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). The Ambulatory EHR market is dominated by Cerner Corporation (U.S.) and McKesson Corporation (U.S.) Cerner Corporation (U.S.) is one of the largest players in the market. In order to remain competitive, the company primarily adopted growth strategies such as agreements, collaborations, and partnerships for enhancing its presence in the market. For instance, in 2016, The UAE Ministry of Health and Prevention (MOHAP) renewed its strategic agreement with Cerner Corporation. Similarly, in 2015, Truman Medical Centers (TMC) (U.S.) partnered with Cerner Corporation to leverage Cerner’s health care information technology (IT) solutions. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235617627 Epic Corporation (U.S.) is another prominent player in the amb

According to research report the global thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period. Over the last few years, the thrombectomy devices market has witnessed significant advancements in terms of the product development and commercialization. The major factors driving the growth of the market are growing target patient population, ongoing technological advancements in thrombectomy devices, favorable medical reimbursement scenario, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets. In this report, the market has been segmented by type, application, end user, and region. In 2016, North America held the largest share of the market. However, the developing Asia-Pacific countries including China and India are expected to emerge as the new revenue-generating regions for prominent market players during 2017-2022. The growth of

According to research report the surgical drains market is expected to reach USD 2.18 Billion by 2022 from USD 1.82 Billion in 2017, growing at a CAGR of 3.7%. The growth of this market is mainly driven by the growing geriatric population, increasing number of surgical procedures, and rising awareness programs globally. Expansions accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Medtronic (Ireland), B. Braun (Germany), Cardinal Health (US), Stryker (US), and Cook Medical (US). The surgical drains market is highly competitive with several big and small players. Prominent players in this market include B. Braun (Germany), Cardinal Health (US), ConvaTec (UK), C.R. Bard (US), Redax (Italy), Ethicon (US), Stryker (US), Romsons (India), Medtronic (Ireland), Medline Industries (US), Cook Medical (US), Poly Medicure (India), Zimmer Biomet (Indiana), Global Medikit (Ind

According to research report Preclinical Imaging Market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. The Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). The key players in the preclinical imaging market focus on various strategies such as product approvals, launches, and enhancements; geographic expansions; partnerships, agreements, and collaborations; and strategic acquisitions in order to increase their market shares in the global preclinical imaging market. Product approvals, launches, and enhancements was the key strategy adopted by major industry players to achieve growth in the preclinical imaging market. This strategy was majorly adopted by PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), and Aspect Imaging Ltd. (Israel). Apart

According to research report the report the Vaccine Adjuvants Market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5% from 2016 to 2021. The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the vaccine adjuvants market along with the estimates and forecasts of the revenue and market share analysis.               The global vaccine adjuvants market The major factors driving the growth of this market are high prevalence of infectious and zoonotic diseases, increasing focus on immunization programs by various government bodies, and growing focus on improved and long-lasting immunization against existing and emerging diseases. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=152603894 The report segments this market into product type, route of administration, disease type, applications, and application categor

According to research report the Cell Expansion Market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6% from 2016 to 2021. The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cell expansion market along with the estimates and forecasts of the revenue and market share analysis. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=194978883 The cell expansion market is consolidated in nature due to the presence of a few large players. The prominent players in the market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.). Thermo Fisher Scientific Inc. (U.S.) was the

According to the new market research Medical Image Management Market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period. Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the medical image management market. On the other hand, budgetary constraints and longer product lifecycle of VNA may limit market growth to a certain extent during the forecast period. Speak to Analyst @   https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=240573338    The PACS segment is expected to dominate the medical image management market in 2018. Based on product, the medical image man

According to the new market research report  eHealth Market is expected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%. Factors driving market growth include the regulatory mandates and government initiatives for the implementation of eHealth solutions; growing mHealth, telehealth, and remote patient monitoring markets; and increasing need to curtail the escalating healthcare costs. In addition, the emerging market in China, India, and Australia; rising shift towards patient-centric healthcare delivery; and growing use of eHealth solutions in outpatient care facilities are further increasing the demand for eHealth solutions and services. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=11513143 In 2017, the eHealth solutions segment accounted for the largest share of the eHealth market. The eHealth solutions segment will continue to dominate the eHealth market, mainly due to the high demand of eHealth solutio

According to research report the global hyperspectral imaging systems market is projected to reach USD 21.33 billion by 2023 from USD 9.51 billion in 2018, at a CAGR of 17.5%. The growing industrial applications of hyperspectral imaging and increasing funding & investments are the major factors driving the growth of the hyperspectral imaging systems market. Product launches accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018. Some of the companies that adopted this strategy include Headwall Photonics (US), SPECIM (Finland), Telops (Canada), Applied Spectral Imaging (US), and ChemImage Corporation (US). Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=246979343 The hyperspectral imaging systems market comprises several large as well as small players. The prominent players in this market include Headwall Photonics (US), Corning Incorporated (US), SPECIM (Finland), Resonon (US), Telops (C

According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period. The technological advancements in the disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis are the key factors driving the growth of the clinical microbiology market during the forecast period. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=219135367 Strategic analysis of the market developments between 2014 and 2018 revealed that growth strategies such as product launches and enhancements; acquisitions; agreements, partnerships, collaboration; and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the clinical microbiology market. Among these business strategies,

The report  "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022" , The global genome editing market is projected to reach USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5% during the forecast period. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. Speak to Analyst:  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=231037000                                               CRISPR to account for the largest technology segment in the genome editing/genome engineering market in 2017 Th

According to research report the amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 150.6 million in 2017, at a CAGR of 2.8%. Factors driving the growth of this market include the high reliability of amniocentesis, increase in the median age of first-time motherhood, and heavy burden of congenital disorders. The amniocentesis needles market is consolidated in nature due to the presence of a large number of players. The key players in the market are Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK). The key strategy followed by most companies in the amniocentesis needles market is acquisitions. This strategy accounted for the largest share of the overall growth strategies mapped from 2014 to 2017. Some of the leading players who adopted this strategy inclu

According to research report the Microbial Identification Market is expected to reach USD 3.00 Billion by 2022 from USD 2.18 Billion in 2017, at a CAGR of 6.6%. Factors driving the growth of this market include increasing incidence of infectious diseases coupled with epidemic and pandemic outbreaks, growing concerns about food safety, innovations in microbial identification techniques, and government initiatives and funding supporting microbial identification. Instruments are estimated to account for the largest market share in 2017 On the basis of product and service, the microbial identification market is classified into instruments, consumables, and services. The instruments are expected to lead the global microbial identification market in 2017. Factors driving the growth of this segment include the wide use of instruments across applications and technological advancements, which have led to the launch of innovative products. The phenotypic methods segment is estimated to

The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Globally, the competent cells market is witnessing a high growth due to factors such as advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins. Key players operating in this market are focusing on acquisitions to strengthen their position. For instance, in November 2015, Merck KGaA (Germany) completed the acquisition of Sigma-Aldrich Co. LLC. (Germany) for USD 17 billion. Sigma-Aldrich Co., LLC is one of the key manufacturers of competent cells. In addition, in March 2017, Thermo Fisher Scientific, Inc. (U.S.) collaborated with Cell and Gene Therapy Catapult (CGT Catapult) (U.K.). Similarly, in February 2014, Thermo Fisher Scientific, Inc. acquired Life Technologies, Inc. (U.S.) to enhance its presence in the competent cells market.

According to research report qPCR reagents market is poised to reach $1,893.9 Million by 2020 From USD 1,307.0 Million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. Over the last decade, the qPCR industry has witnessed significant technological advancement & robust product development. These advancements are transforming the field of forensic & disease diagnostic application of qPCR; leading to more effective & timely treatment of chronic and infectious diseases (such as cancer, AIDS, influenza, and hepatitis). North America and a major part of Europe are mature markets for qPCR reagents. However, emerging regions such as Asia-Pacific (including China and India) are expected to become new revenue-generating pockets in the market over the next five years. The North American qPCR reagents market is expected to hold the largest share during the forecast period owing to high penetration of qPCR technologies among key end users, increasing public & private

According to research report " Cancer Immunotherapy Market is expected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0% from 2016 to 2021. This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global cancer immunotherapy market along with the estimates and forecasts of the revenue and market share analysis. In this report, the global cancer immunotherapy market has been segmented based on type, application, end user, and region. On the basis of type, the market has been segmented into monoclonal antibodies, cancer vaccines, checkpoint inhibitors, and immunomodulators. The monoclonal antibodies segment is expected to account for the largest share of the market in 2016, while the checkpoint inhibitors segment is projected to witness the highest CAGR from 2016 to 2021. The high growth in this segment is primarily attributed to the high succes

According to research report thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period. The key players focused on various strategies such as product launches and enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase their shares in the global thrombectomy devices market. Product launches & enhancements is the strategy adopted by major industry players to achieve the desired market growth during 2013-2017. This strategy was adopted by Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.). Apart from product launches and enhancements, many prominent players also adopted agreements and collaborations as their k

According to research report the global forensic equipment and supplies market is projected to reach USD 8.7 billion by 2024 from USD 6.0 billion in 2019, at a CAGR of 7.7% during the forecast period. Factors such as the growing number of crimes across major countries, ongoing technological advancements in forensic sciences, growing public-private investments in the field of forensics, and the rising awareness among investigators about the role of DNA profiling in criminology are driving the growth of the forensic equipment and supplies market. However, the high cost of forensic instruments and the dearth of well-skilled technicians to perform forensic analysis in emerging countries are expected to restrain the growth of this market during the forecast period. The major players operating in the forensic equipment and supplies market include Thermo Fisher Scientific (US), PerkinElmer (US), Agilent Technologies (US), Waters Corporation (US), and SCIEX (Danaher Corporation